A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

Abstract Background Renal cell carcinoma (RCC) is a third most common tumor of the urinary system. Nowadays, Immunotherapy is a hot topic in the treatment of solid tumors, especially for those tumors with pre-activated immune state. Methods In this study, we downloaded genomic and clinical data of R...

Full description

Bibliographic Details
Main Authors: Peng Cao, Ji-Yue Wu, Jian-Dong Zhang, Ze-Jia Sun, Xiang Zheng, Bao-Zhong Yu, Hao-Yuan Cao, Fei-Long Zhang, Zi-Hao Gao, Wei Wang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Cancer
Subjects:
Renal cell carcinoma
RCC
Immunologic signature
Tumor immunity
Prognosis
Online Access:https://doi.org/10.1186/s12885-022-09755-2

Internet

https://doi.org/10.1186/s12885-022-09755-2

Similar Items